Germany's Bayer plans €15bn investment through 2013

29 April 2011 10:18  [Source: ICIS news]

SINGAPORE (ICIS)--German specialty chemicals maker Bayer said on Friday it plans to invest €15bn ($22bn) through 2013 primarily for research and development (R&D) to promote technological innovation.

Bayer chairman Marijn Dekkers made the announcement at the company’s annual stockholders' meeting in Cologne, according to a company statement.

Two-thirds of the investment will be used for R&D expenses, while the remaining balance will go towards capital expenditures, said Dekkers.

“The company plans to keep its research and development expenditures in 2011 level with the record €3.1bn spent in 2010,” he said.

Notwithstanding a 4.3% year-on-year fall in net profit last year to €1.3bn, Bayer has proposed a higher dividend of €1.50 for the year from €1.40 in 2009, the company said.

The figure is equivalent to a total dividend payment of €1.24bn, it added.

In the first quarter of 2011, Bayer posted an 8.4% year-on-year increase in net profit to €684m, with sales rising 13.2% to €9.4bn.

($1 = €0.67)

By: Pearl Bantillo
+65 6780 4359

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly